Golgi-restored vesicular replenishment retards bone aging and empowers aging bone regeneration

Abstract

Healthy aging is a common goal for humanity and society, and one key to achieving it is the rejuvenation of senescent resident stem cells and empowerment of aging organ regeneration. However, the mechanistic understandings of stem cell senescence and the potential strategies to counteract it remain elusive. Here, we reveal that the aging bone microenvironment impairs the Golgi apparatus thus diminishing mesenchymal stem cell (MSC) function and regeneration. Interestingly, replenishment of cell aggregates-derived extracellular vesicles (CA-EVs) rescues Golgi dysfunction and empowers senescent MSCs through the Golgi regulatory protein Syntaxin 5. Importantly, in vivo administration of CA-EVs significantly enhanced the bone defect repair rate and improved bone mass in aging mice, suggesting their therapeutic value for treating age-related osteoporosis and promoting bone regeneration. Collectively, our findings provide insights into Golgi regulation in stem cell senescence and bone aging, which further highlight CA-EVs as a potential rejuvenative approach for aging bone regeneration.

References

[1] Cui J, Shibata Y, Zhu T, Zhou J, Zhang J. Osteocytes in bone aging: advances, challenges, and future perspectives. Ageing Res. Rev., 2022, 77 101608.

[2] Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol, 2017, 5 898-907.

[3] Sui BD, Zheng CX, Li M, Jin Y, Hu CH. Epigenetic regulation of mesenchymal stem cell homeostasis. Trends Cell Biol., 2020, 30 97-116.

[4] Sui BD . Stem cell-based bone regeneration in diseased microenvironments: Challenges and solutions. Biomaterials, 2019, 196 18-30.

[5] Goodell MA, Rando TA. Stem cells and healthy aging. Science, 2015, 350 1199-1204.

[6] Lin H, Sohn J, Shen H, Langhans MT, Tuan RS. Bone marrow mesenchymal stem cells: aging and tissue engineering applications to enhance bone healing. Biomaterials, 2019, 203 96-110.

[7] Cheng C, Wentworth K, Shoback DM. New frontiers in osteoporosis therapy. Annu. Rev. Med., 2020, 71 277-288.

[8] Khandelwal S, Lane NE. Osteoporosis: review of etiology, mechanisms, and approach to management in the aging population. Endocrinol. Metab. Clin. North Am., 2023, 52 259-275.

[9] Chandra, A. & Rajawat, J. Skeletal aging and osteoporosis: mechanisms and therapeutics. Int. J. Mol. Sci. 22, 3553 (2021).

[10] Gong L . Human ESC-sEVs alleviate age-related bone loss by rejuvenating senescent bone marrow-derived mesenchymal stem cells. J. Extracell. Vesicles., 2020, 9 1800971.

[11] Sui BD, Zhu B, Hu CH, Zhao P, Jin Y. Reconstruction of regenerative stem cell niche by cell aggregate engineering. Methods Mol. Biol., 2019, 2002 87-99.

[12] Li, S. et al. Construction, characterization, and regenerative application of self-assembled human mesenchymal stem cell aggregates. J. Vis. Exp. e64697, https://doi.org/10.3791/64697 (2023).

[13] Sui BD . Mesenchymal condensation in tooth development and regeneration: a focus on translational aspects of organogenesis. Physiol. Rev., 2023, 103 1899-1964.

[14] Liu L . Mesenchymal stem cell aggregation-released extracellular vesicles induce CD31⁺ EMCN⁺ vessels in skin regeneration and improve diabetic wound healing. Adv. Healthc. Mater., 2023, 12. e2300019

[15] Xuan, K. et al. Deciduous autologous tooth stem cells regenerate dental pulp after implantation into injured teeth. Sci. Transl. Med. 10, eaaf3227 (2018).

[16] Guo H . Odontogenesis-related developmental microenvironment facilitates deciduous dental pulp stem cell aggregates to revitalize an avulsed tooth. Biomaterials, 2021, 279 121223.

[17] Miura M . SHED: stem cells from human exfoliated deciduous teeth. Proc. Natl. Acad. Sci. USA., 2003, 100 5807-5812.

[18] Buzas EI. The roles of extracellular vesicles in the immune system. Nat. Rev. Immunol., 2023, 23 236-250.

[19] Couch Y . A brief history of nearly EV-erything - The rise and rise of extracellular vesicles. J. Extracell. Vesicles., 2021, 10. e12144

[20] Huang, X. et al. Odontogenesis-empowered extracellular vesicles safeguard donor-recipient stem cell interplay to support tooth regeneration. Small. 20, e2400260 (2024).

[21] Deng P . Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. Cell Stem Cell, 2021, 28 1057-1073.e1057.

[22] Hu M . NAP1L2 drives mesenchymal stem cell senescence and suppresses osteogenic differentiation. Aging Cell, 2022, 21. e13551

[23] Shen J . Skeleton-derived extracellular vesicles in bone and whole-body aging: from mechanisms to potential applications. Bone, 2024, 183 117076.

[24] Sui B . Apoptotic vesicular metabolism contributes to organelle assembly and safeguards liver homeostasis and regeneration. Gastroenterology, 2024, 167 343-356.

[25] Sui BD, Hu CH, Zheng CX, Jin Y. Microenvironmental views on mesenchymal stem cell differentiation in aging. J. Dent. Res., 2016, 95 1333-1340.

[26] Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J. Bone Miner. Res., 2003, 18 696-704.

[27] Welsh JA . Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J. Extracell. Vesicles., 2024, 13. e12404

[28] Mallard F . Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform. J. Cell. Biol., 2002, 156 653-664.

[29] Zeng Q, Tran TT, Tan HX, Hong W. The cytoplasmic domain of Vamp4 and Vamp5 is responsible for their correct subcellular targeting: the N-terminal extenSion of VAMP4 contains a dominant autonomous targeting signal for the trans-Golgi network. J. Biol. Chem., 2003, 278 23046-23054.

[30] Zhang X, Wang Y. Nonredundant roles of GRASP55 and GRASP65 in the golgi apparatus and beyond. Trends Biochem. Sci., 2020, 45 1065-1079.

[31] Zhang, Y. & Seemann, J. Rapid degradation of GRASP55 and GRASP65 reveals their immediate impact on the Golgi structure. J. Cell. Biol. 220, e202007052 (2021).

[32] Hay JC, Chao DS, Kuo CS, Scheller RH. Protein interactions regulating vesicle transport between the endoplasmic reticulum and Golgi apparatus in mammalian cells. Cell, 1997, 89 149-158.

[33] Urano Y . Transport of LDL-derived cholesterol from the NPC1 compartment to the ER involves the trans-Golgi network and the SNARE protein complex. Proc. Natl. Acad. Sci. USA., 2008, 105 16513-16518.

[34] Campisi J . From discoveries in ageing research to therapeutics for healthy ageing. Nature, 2019, 571 183-192.

[35] Qiu HL . Global burden and drivers of hyperglycemia: estimates and predictions from 1990 to 2050. Innovation, 2023, 4 100450

[36] Schmich J . Induction of reverse development in two marine Hydrozoans. Int. J. Dev. Biol., 2007, 51 45-56.

[37] Ermolaeva M, Neri F, Ori A, Rudolph KL. Cellular and epigenetic drivers of stem cell ageing. Nat. Rev. Mol. Cell Biol., 2018, 19 594-610.

[38] Ensrud KE, Crandall CJ. Osteoporosis. Ann. Intern. Med., 2024, 177 Itc1-itc16.

[39] Huang HK . Denosumab and the risk of diabetes in patients treated for osteoporosis. JAMA Netw. Open., 2024, 7. e2354734

[40] Zhang Y . 3D-bioprinted anisotropic bicellular living hydrogels boost osteochondral regeneration via reconstruction of cartilage-bone interface. Innovation, 2024, 5 100542

[41] Gnecchi M . Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med., 2005, 11 367-368.

[42] Xin H . MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells, 2013, 31 2737-2746.

[43] Holliday LS, Patel SS, Rody WJ Jr.. RANKL and RANK in extracellular vesicles: surprising new players in bone remodeling. Extracell. Vesicles Circ. Nucl. Acids., 2021, 2 18-28

[44] Li X . Inflammation and aging: signaling pathways and intervention therapies. Signal. Transduct. Target. Ther., 2023, 8 239.

[45] Moiseeva V . Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration. Nature, 2023, 613 169-178.

[46] Lin Z . Hydrogenated silicene nanosheet functionalized scaffold enables immuno-bone remodeling. Exploration, 2023, 3 20220149.

[47] Lei, Q. et al. Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow-derived mesenchymal stem cells and slow age-related degeneration. Sci. Transl. Med. 13, eaaz8697 (2021).

[48] Ng AH . Adynamic bone decreases bone toughness during aging by affecting mineral and matrix. J. Bone Miner. Res., 2016, 31 369-379.

[49] Xie H . PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat. Med., 2014, 20 1270-1278.

[50] Ambrosi TH . Aged skeletal stem cells generate an inflammatory degenerative niche. Nature, 2021, 597 256-262.

[51] Farr JN . Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med., 2017, 23 1072-1079.

[52] Altyar AE . Future regenerative medicine developments and their therapeutic applications. Biomed. Pharmacother., 2023, 158 114131.

[53] Hashimoto S, Nagoshi N, Nakamura M, Okano H. Regenerative medicine strategies for chronic complete spinal cord injury. Neural Regen. Res., 2024, 19 818-824.

[54] Van Gelder RN . Regenerative and restorative medicine for eye disease. Nat. Med., 2022, 28 1149-1156.

[55] Bao H . Biomarkers of aging. Sci. China Life Sci., 2023, 66 893-1066.

[56] Zheng CX, Sui BD, Jin Y. Harnessing mesenchymal aggregation for engineered organ-level regeneration: Recent progress and perspective. Aggregate, 2023, 4 1-22

[57] Yong T, Wei Z, Gan L, Yang X. Extracellular-vesicle-based drug delivery systems for enhanced antitumor therapies through modulating the cancer-immunity cycle. Adv. Mater., 2022, 34. e2201054

[58] Al-Masawa ME . Efficacy and safety of small extracellular vesicle interventions in wound healing and skin regeneration: A systematic review and meta-analysis of animal studies. Theranostics, 2022, 12 6455-6508.

[59] Feng Q . The dissolution, reassembly and further clearance of amyloid-beta fibrils by tailor-designed dissociable nanosystem for Alzheimer’s disease therapy. Exploration, 2024, 4 20230048.

[60] Haltom, A. R. et al. Engineered exosomes targeting MYC reverse the proneural-mesenchymal transition and extend survival of glioblastoma. Extracell. Vesicle. 1, 100014 (2022).

[61] Popowski KD . Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung. Extracell. Vesicle., 2022, 1 100002.

[62] Sun B . Engineered induced-pluripotent stem cell derived monocyte extracellular vesicles alter inflammation in HIV humanized mice. Extracell. Vesicles Circ. Nucl. Acids., 2022, 3 118-132.

[63] Ansari, S. et al. Matrix vesicles: role in bone mineralization and potential use as therapeutics. Pharmaceuticals. 14, 289 (2021).

[64] Wang J . Bone-targeted exosomes: strategies and applications. Adv. Healthc. Mater., 2023, 12. e2203361

[65] Tao Y, Yang Y, Zhou R, Gong T. Golgi apparatus: an emerging platform for innate immunity. Trends Cell Biol, 2020, 30 467-477.

[66] Wijaya CS, Xu S. Reevaluating Golgi fragmentation and its implications in wound repair. Cell Regen, 2024, 13 4.

[67] Choi HS . COG-imposed Golgi functional integrity determines the onset of dark-induced senescence. Nat. Plants., 2023, 9 1890-1901.

[68] Cho JH, Saini DK, Karunarathne WK, Kalyanaraman V, Gautam N. Alteration of Golgi structure in senescent cells and its regulation by a G protein γ subunit. Cell Signal, 2011, 23 785-793.

[69] Li J, Ahat E, Wang Y. Golgi structure and function in health, stress, and diseases. Results Probl. Cell Differ., 2019, 67 441-485.

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81930025)

RIGHTS & PERMISSIONS

The Author(s)